[go: up one dir, main page]

MX376035B - Composiciones y métodos para la administración transdermica de anfetamina. - Google Patents

Composiciones y métodos para la administración transdermica de anfetamina.

Info

Publication number
MX376035B
MX376035B MX2016008207A MX2016008207A MX376035B MX 376035 B MX376035 B MX 376035B MX 2016008207 A MX2016008207 A MX 2016008207A MX 2016008207 A MX2016008207 A MX 2016008207A MX 376035 B MX376035 B MX 376035B
Authority
MX
Mexico
Prior art keywords
amphetamine
compositions
methods
drug delivery
transdermal drug
Prior art date
Application number
MX2016008207A
Other languages
English (en)
Other versions
MX2016008207A (es
Inventor
Jun Liao
Steven Dinh
Viet Nguyen
Original Assignee
Noven Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Noven Pharma filed Critical Noven Pharma
Publication of MX2016008207A publication Critical patent/MX2016008207A/es
Publication of MX376035B publication Critical patent/MX376035B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen composiciones transdérmicas para suministro de fármacos que comprenden anfetamina, métodos de fabricación de composiciones transdérmicas para suministro de fármacos que comprenden anfetamina, y métodos terapéuticos que usan composiciones transdérmicas para suministro de fármacos que comprenden anfetamina, tales como puedan desearse para lograr la estimulación del sistema nervioso central, tales como para el tratamiento de trastorno por déficit de atención (ADD) trastorno de hiperactividad con déficit de atención (ADHD), o para el tratamiento de narcolepsia. En algunas modalidades, las composiciones comprenden una cantidad de poliuretano efectiva para controlar la presencia de y/o evitar la formación de fenil acetona en las composiciones. El poliuretano puede estar presente en una matriz de polímero que contiene fármaco o en un respaldo adyacente a la matriz de polímero que contiene fármaco.
MX2016008207A 2013-12-23 2014-12-19 Composiciones y métodos para la administración transdermica de anfetamina. MX376035B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361919955P 2013-12-23 2013-12-23
PCT/US2014/071406 WO2015100153A1 (en) 2013-12-23 2014-12-19 Compositions and methods for transdermal delivery of amphetamine

Publications (2)

Publication Number Publication Date
MX2016008207A MX2016008207A (es) 2016-10-14
MX376035B true MX376035B (es) 2025-03-07

Family

ID=52282996

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016008207A MX376035B (es) 2013-12-23 2014-12-19 Composiciones y métodos para la administración transdermica de anfetamina.

Country Status (8)

Country Link
EP (1) EP3086783B1 (es)
AR (1) AR098878A1 (es)
AU (1) AU2014370133A1 (es)
CA (1) CA2934924C (es)
ES (1) ES2687344T3 (es)
MX (1) MX376035B (es)
TW (1) TWI674900B (es)
WO (1) WO2015100153A1 (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4655767A (en) 1984-10-29 1987-04-07 Dow Corning Corporation Transdermal drug delivery devices with amine-resistant silicone adhesives
US4591622A (en) 1984-10-29 1986-05-27 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product thereof
US4584355A (en) 1984-10-29 1986-04-22 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product with improved lap-shear stability-I
US4585836A (en) 1984-10-29 1986-04-29 Dow Corning Corporation Silicone pressure-sensitive adhesive process and product with improved lap-shear stability-II
US6337086B1 (en) 1999-02-06 2002-01-08 Dow Corning Corporation Pressure sensitive adhesive compositions for transdermal drug delivery devices
NZ546992A (en) * 2003-10-28 2009-07-31 Noven Pharma Transdermal drug delivery device
ES2596809T3 (es) * 2004-10-08 2017-01-12 Noven Pharmaceuticals, Inc. Dispositivo de administración transdérmica de fármacos que incluye un refuerzo oclusivo
US9474722B2 (en) * 2012-10-25 2016-10-25 Noven Pharmaceuticals, Inc. Compositions and methods for transdermal delivery of amphetamine

Also Published As

Publication number Publication date
AR098878A1 (es) 2016-06-22
MX2016008207A (es) 2016-10-14
EP3086783B1 (en) 2018-08-29
AU2014370133A1 (en) 2016-08-04
EP3086783A1 (en) 2016-11-02
TW201534310A (zh) 2015-09-16
WO2015100153A1 (en) 2015-07-02
CA2934924A1 (en) 2015-07-02
CA2934924C (en) 2022-05-03
ES2687344T3 (es) 2018-10-24
TWI674900B (zh) 2019-10-21

Similar Documents

Publication Publication Date Title
UA117098C2 (uk) Сполука, що містить модифікований олігонуклеотид
MX2022013590A (es) Metodos y composiciones para el tratamiento de trastorno por deficit de atencion.
CO7180225A2 (es) Tratamientos de combinación para melanoma que comprenden la administración de cobimetinib y vemurafenib
BR112018006636A2 (pt) composições de oligonucleotídeo e métodos destas
MX382516B (es) Composiciones y metodos para absorcion transmucosa.
MX2023000796A (es) Composicion farmaceutica, metodos para tratamiento y sus usos.
GT201500294A (es) Compuestos de biaril-amida como inhibidores de cinasa
MX2016006623A (es) Compuestos de inhibidor de autotaxina.
MX383590B (es) Inhibidores de kdm1a para el tratamiento de enfermedades.
NZ719520A (en) Mirna and its diagnostic and therapeutic uses in diseases or conditions associated with melanoma, or in diseases or conditions associated with activated braf pathway
BR112015029386A2 (pt) uso de eribulina e lenvatinibe como terapia de combinação para tratamento de câncer
CL2014000210A1 (es) Una composicion de prodroga que comprende al menos un conjugado de metilfenidato; kit farmaceutico que la comprende, util para el tratamiento de una enfermedad o condicion que requiere estimulacion del sistema nervioso tal como un trastorno de hiperactividad con deficit de atencion y depresion.
CL2015002680A1 (es) Composición farmaceutica que comprende un activador de ampk y un agente serotoninérgico y método para usar los mismos
MX390120B (es) Moduladores de la somatostatina y usos de los mismos.
MX2019003173A (es) Terapia de combinacion con agonistas de peptido natriuretico tipo c (cnp) de liberacion controlada.
GB201111485D0 (en) Drug composition and its use in therapy
MX2019007391A (es) Sistema terapeutico transdermico que contiene asenapina.
BR112017018964A2 (pt) uso de plinabulin e métodos para tratar tumor cerebral
MX2016009284A (es) Construcciones dirigidas a receptor y sus usos.
AR093118A1 (es) Composiciones y metodos para la administracion transdermica de anfetamina
NI201600070A (es) Inhibidores tetracíclicos de autotaxina
MX2016005446A (es) Intervenciones a base de angiopoyetina para tratar la malaria cerebral.
BR112015010039A2 (pt) tratamento de câncer com pomalidomida em um individuo com disfunção renal
WO2014153385A3 (en) Methods of treating metabolic disorders
AR094289A1 (es) Sistemas de administracion transdermica de farmacos para levonorgestrel y etinil estradiol

Legal Events

Date Code Title Description
FG Grant or registration